• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

COVID-19 during pregnancy ramps up serious health risks

Bioengineer by Bioengineer
January 17, 2023
in Health
Reading Time: 3 mins read
0
3 Questions with Emily Smith
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WASHINGTON (Jan. 16, 2023)—Pregnant women who are infected with the virus that causes COVID-19 face a 7 times increased risk of dying and a significantly elevated risk of being admitted to an intensive care unit or suffering from pneumonia, according to research published today in BMJ Global Health. The study also suggests that COVID-19 during pregnancy also increases the risk that the baby will need to be admitted to intensive care.

3 Questions with Emily Smith

Credit: Video belongs to the George Washington University

WASHINGTON (Jan. 16, 2023)—Pregnant women who are infected with the virus that causes COVID-19 face a 7 times increased risk of dying and a significantly elevated risk of being admitted to an intensive care unit or suffering from pneumonia, according to research published today in BMJ Global Health. The study also suggests that COVID-19 during pregnancy also increases the risk that the baby will need to be admitted to intensive care.

“This study provides the most comprehensive evidence to date suggesting that COVID-19 is a threat during pregnancy,” Emily R. Smith, an assistant professor of global health at the George Washington University Milken Institute School of Public Health and lead author of the study, said. “Our findings underscore the importance of COVID-19 vaccination for all women of childbearing age.”

Despite growing knowledge about the risks of COVID-19 during pregnancy, many women of childbearing age in the United States and other countries remain unvaccinated. In some cases, women hesitate or refuse to get the vaccine or booster shot because they don’t think COVID-19 poses risks to young women or they feel unsure about the safety of the vaccine  during pregnancy. Even some doctors may hesitate to give the vaccine to a pregnant woman, Smith says, even though it is recommended.

Smith and her colleagues pooled individual patient data from 12 studies conducted in 12 countries, including the United States, involving more than 13,000 pregnant women.

The researchers found that compared to uninfected pregnant women, pregnant women with COVID-19 infection were at:

  • Seven times higher risk of dying during pregnancy or childbirth;.
  • More than three times greater risk of being admitted to the intensive care unit. People with COVID-19 who need ICU care are also more likely to die.
  • About 15 times higher risk of needing ventilator treatment. COVID-19 can affect the ability to breathe and in severe cases patients need mechanical ventilation in order to survive.
  • About 23 times higher risk of developing pneumonia, a potentially life threatening complication of COVID-19.
  • More than 5 times higher risk of thromboembolic disease, or blood clots, that can cause pain, swelling, or other life-threatening complications. 

Neonates born to women who were infected with COVID-19 were almost twice as likely to be admitted to a neonatal intensive care unit after birth. They were also at higher risk of being born prematurely. Preterm babies are at high risk of having lifelong health problems including delays in early childhood cognitive development, Smith said.

Despite the very serious health risks, more than 80 countries still do not recommend that all pregnant and lactating women get the COVID vaccine, Smith points out. While it was hard to put together the evidence in the past, this meta analysis provides public health officials and the public with clear, consistent and compelling findings, she adds.

“This study shows the risk of getting COVID-19 for both mother and baby,” Smith said. “All countries, including the United States, should make access to COVID vaccines an urgent priority in order to save lives and prevent health problems.”

The study, “Adverse maternal, fetal and newborn outcomes among 1942 pregnant women with SARS-CoV-2 infection, as compared to 11194 negative pregnancies: A individual participant data meta-analysis,” was published in the Jan. 16, 2023 issue of BMJ Public Health. 

Watch a video of lead researcher Emily Smith discussing the research here.

The research was supported by grant funding from the Bill & Melinda Gates Foundation.

-GW-

 



Journal

BMJ Global Health

DOI

10.1136/bmjgh-2022-009495

Method of Research

Meta-analysis

Subject of Research

People

Article Title

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis

Article Publication Date

16-Jan-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.